Synergy Chc Corp is a public company that specializes in developing innovative healthcare solutions, primarily focusing on creating and distributing pharmaceutical products and dietary supplements. The company emphasizes research and development to enhance the effectiveness and accessibility of its offerings, catering to various health needs. Through strategic partnerships and a commitment to quality, Synergy Chc Corp aims to improve patient outcomes and contribute positively to the wellness industry. Its portfolio potentially spans over a range of therapeutic areas, positioning the company as a key player in the healthcare market. Read More
Synergy CHC Corp. (NASDAQ: SNYR), a leading provider of consumer health care and lifestyle products, has reported strong financial results for the first quarter ended March 31, 2025, marking its ninth consecutive quarter of profitability and signaling solid momentum for investors.
Synergy CHC Corp. (NASDAQ: SNYR), a consumer health and wellness brand powerhouse, reported 30% year-over-year EPS growth and its ninth straight profitable quarter . EBITDA margin jumped to 24.1%, fueled by cost discipline and strong brand traction for FOCUSfactor and Flat Tummy .
NEW YORK CITY, NEW YORK / ACCESS Newswire / April 17, 2025 / Synergy CHC Corp. (NASDAQ:SNYR), a leading consumer health and wellness company, proudly announces its participation in a six-part featured series on the acclaimed business television program "New to The Street", airing as sponsored programming on FOX Business and Bloomberg Television.
Invizyne Technologies opened on Nov. 13 at $11.10. Shares gained as much as 13% following the company's $15 million initial public offering. Additionally, Alpha Cognition opened on Nov. 12 at $7.00.
Ingram Micro and its private equity owner, Platinum Equity, sold 18.6 million shares at $22 each as the technology distributor returned to public trading in a busy week for the IPO market.
